Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms Jack Chovanec , Ilker Tunc , Jason Hughes , Joseph Halstead , Allyson Mateja , Yihui Liu , Michael P. O’Connell , Jiwon Kim , Young Hwan Park , Qinlu Wang , Quang Le , Mehdi Pirooznia , Neil N. Trivedi , Yun Bai , Yuzhi Yin , Amy P. Hsu , Josh McElwee , Sheryce Lassiter , Celeste Nelson , Judy Bandoh , Thomas DiMaggio , Julij Šelb , Matija Rijavec , Melody C. Carter , Hirsh D. Komarow , Vito Sabato , Joshua Steinberg , Kurt M. Hafer , Elizabeth Feuille , Christopher S. Hourigan , Justin Lack , Paneez Khoury , Irina Maric , Roberta Zanotti , Patrizia Bonadonna , Lawrence B. Schwartz , Joshua D. Milner , Sarah C. Glover , Didier G. Ebo , Peter Korošec , George H. Caughey , Erica H. Brittain. , Ben Busby , Dean D. Metcalfe , Jonathan J. Lyons medRxiv (Cold Spring Harbor Laboratory)（2022）
关键词
biomarker tryptase, individualized clinical reference
AI 理解论文
溯源树
样例
